These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Possibilities to elevate the factor VIII yield]. Uteg KH, Tausendfreund K. Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(1):153-69. PubMed ID: 2439416 [Abstract] [Full Text] [Related]
7. A comparison of the in vitro and in vivo thrombogenic activity of factor IX concentrates using stasis (Wessler) and non-stasis rabbit models. Prowse CV, Williams AE. Thromb Haemost; 1980 Oct 31; 44(2):81-6. PubMed ID: 6779401 [Abstract] [Full Text] [Related]
8. In vitro thrombogenicity tests of factor IX concentrates. II: effects of phospholipids and heparin. Prowse CV, Boffa MC, Guthrie C, Pepper DS. Thromb Haemost; 1980 Feb 29; 42(5):1368-77. PubMed ID: 7368144 [Abstract] [Full Text] [Related]
12. [Changes in ionized calcium and citrate levels in dogs during mechanical autotransfusion with heparin, ACD and CPD]. Klaue P, Maier H, Feldmann K, Homann B. Chir Forum Exp Klin Forsch; 1979 Feb 29; ():255-9. PubMed ID: 456136 [Abstract] [Full Text] [Related]
18. Products for the treatment of hemophilia A and B prepared by ion exchange chromatography. Sultan Y, Boyeldieu D, Stieltjes N. Nouv Rev Fr Hematol (1978); 1994 Mar 29; 36 Suppl 1():S59-60. PubMed ID: 8177717 [Abstract] [Full Text] [Related]
19. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF. Thromb Haemost; 1997 Mar 29; 77(3):477-80. PubMed ID: 9065997 [Abstract] [Full Text] [Related]
20. The quality of plasma collected by automated apheresis and of recovered plasma from leukodepleted whole blood. Runkel S, Haubelt H, Hitzler W, Hellstern P. Transfusion; 2005 Mar 29; 45(3):427-32. PubMed ID: 15752162 [Abstract] [Full Text] [Related] Page: [Next] [New Search]